PDSB – pds biotechnology corporation (US:NASDAQ)
Stock Stats
News
PDS Biotechnology (PDSB) had its "buy" rating reaffirmed by HC Wainwright. They now have a $15.00 price target on the stock.
PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial
PDS Biotechnology (PDSB) was upgraded by Wall Street Zen from "sell"
PDS Biotechnology Corp (PDSB) Q4 2025 Earnings Call Highlights: Financial Discipline Amid ... [Yahoo! Finance]
PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement [Yahoo! Finance]
Form 8-K PDS Biotechnology Corp For: Apr 15
Form 10-K PDS Biotechnology Corp For: Dec 31
Form 8-K PDS Biotechnology Corp For: Mar 30
Form 4 PDS Biotechnology Corp For: Jan 12 Filed by: Freitag Gregory Gene
Form 4 PDS Biotechnology Corp For: Jan 12 Filed by: Brown Spencer D.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.